Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,603 public trials 2,148 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT06172478

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +70 more
Locations
  • City of Hope Duarte, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Kissimmee, Florida, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
View all 85 locations
View Trial Details
Recruiting

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

NCT06517810

Conditions
Acute Kidney Injury, Acute Kidney Injury Due to Sepsis, Female Urogenital Diseases, +9 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Lucile Packard Children's Hospital Stanford Palo Alto, California, United States
  • UCSF Benioff Children's San Francisco, California, United States
  • HealthONE HCA Rocky Mountain Children's Hospital Denver, Colorado, United States
View all 15 locations
View Trial Details
Recruiting

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

NCT06699849

Conditions
Acute Chest Syndrome, Acute Kidney Injury, Anemia, +20 more
Locations
  • Univ. of California, San Francisco Health Care Oakland, California, United States
  • University of California Irvine Orange, California, United States
  • Golisano Children's Hospital Fort Myers, Florida, United States
  • The Foundation for Sickle Cell Disease Hollywood, Florida, United States
View all 19 locations
View Trial Details
Recruiting

A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)

NCT06708949

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Penn Medicine Abramson Cancer Center Philadelphia, Pennsylvania, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details

Related conditions